Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
17.28
-1.07 (-5.83%)
At close: Nov 2, 2026, 4:00 PM EST
17.30
+0.02 (0.12%)
After-hours: Nov 2, 2026, 7:30 PM EST
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $3.79 billion as of November 2, 2026. It is the 4,362nd most valuable company in the world and the 1,352nd biggest in the United States. Its market cap has increased by 207.61% in one year.
Market Cap
3.79B
Enterprise Value
2.91B
1-Year Change
207.61%
Global Rank
Country Rank
#1,352 United States
Category
ChartMarket Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has increased from $3.03B to $3.79B, an increase of 24.78%. That is a compound annual growth rate of 3.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 3.79B | 158.25% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 4.61B |
| Edgewise Therapeutics | 4.22B |
| Legend Biotech | 4.19B |
| Arcutis Biotherapeutics | 4.03B |
| AbCellera Biologics | 3.98B |
| Iovance Biotherapeutics | 3.84B |
| Tango Therapeutics | 3.83B |
| Xenon Pharmaceuticals | 3.62B |